India Insulin Infusion Pump Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | > 3.00 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
India Insulin Infusion Pump Market Analysis
India's Insulin Infusion Pumps Market is expected to register a CAGR of more than 3% and reach a value of about USD 23 million over the forecast period.
Diabetes was a significant risk factor for a severe COVID-19 course. Several diabetes-related factors, including advanced age, hyperglycemia, and underlying diseases (hypertension, cardiovascular disease, chronic renal disease, and obesity), were believed to impact this risk. During the COVID-19 pandemic, diabetes was soon identified as a risk factor for unfavorable outcomes, making diabetes control or delay more critical than ever.
Diabetes mellitus, or diabetes in general, is defined by high blood glucose levels. Type 1 diabetes is caused by a total absence of insulin, often known as insulin-dependent diabetes mellitus. Type 2 diabetes mellitus is a disorder in which the body either does not create enough insulin or is unable to use the insulin that it does make. Diabetes type 2 is classified as a disease of lifestyle. Sugary treats, as well as historical practices and religious events, are an important component of Indian culture. According to an article published in "THE HINDU," India accounts for one out of every six diabetes globally. Data show that the country has an estimated 80 million diabetics, placing it second in the world. Diabetes affects over half of all Indians at some point in their lives, making it a major public health problem. Type 2 diabetes is becoming more common in rural India. This drives the market forward and accelerates the adoption of new and advanced technologies.
An insulin infusion pump is an alternative to the usual approach of daily injections or an insulin pen. Insulin infusion pumps prevent significant fluctuations in blood glucose levels, reduce discomfort, and provide insulin more precisely than injections. When employing pumps, meal timings are not necessary. This makes infusion pumps more user-friendly for patients. Insulin treatment is also known as continuous subcutaneous insulin infusion (CSII). It is an effective and versatile insulin delivery technique. The insulin pump has progressed and is now more dependable than it was previously. CSII technology has seen several technical breakthroughs, including the integration of continuous glucose monitoring with the pump. Insulin pumps may now regulate the algorithm that automatically delivers insulin after analyzing the blood glucose data.
India Insulin Infusion Pump Market Trends
Insulin Pump is Expected to Witness Growth Over the Forecast Period
An insulin pump is a device that automatically distributes insulin on a continuous or as-needed basis. The pump is modeled after the human pancreas. The insulin infusion pump can be used instead of the standard regimen of daily injections or an insulin pen. Insulin pump treatment is a well-known insulin delivery technique for people with type 1 diabetes (T1DM). Pumps are a recognized, time-tested treatment alternative for T1DM patients of all ages, providing near-physiological insulin administration when the pancreas does not make insulin. There are also pump variants with remote controllers that allow parents to suspend or bolus insulin from a distance while their child is playing or eating. When compared to injections, insulin infusion pumps prevent big fluctuations in blood glucose levels, cause less discomfort, and dispense more precisely. The benefits of insulin pumps over traditional delivery systems are projected to drive market growth.
Continuous subcutaneous insulin infusion (CSII, also known as insulin pumps) and continuous glucose monitoring systems (CGMs) have significantly improved patient care and quality of life and are commonly utilized in the ambulatory context. This technology is increasingly being employed in the healthcare setting.
Because of the rising obesity incidence, increasing hereditary risks for type 2 diabetes, and an increasing number of Type 1 diabetes patients, the insulin infusion pump industry is expected to expand further.
Rising diabetes prevalence
In India, Diabetes Population is expected to increase with a CAGR of more than 1% over the forecast period.
Diabetes already affects more than 80 million Indians and is expected to affect 10% of the Indian population by 2027. Obesity, particularly central obesity and increased visceral fat as a result of inactivity, as well as intake of high-calorie/high-fat/high-sugar meals, are key risk factors for diabetes among Indians. The country's most prevalent work culture, which consists of sitting for hours in one position and eating fast food with little or no physical activity, is a key contributor to diabetes in the working-age population, resulting in a considerable increase in diabetes cases in India.
Diabetes accounts for 10% of global health spending in India, according to the International Diabetes Federation (IDF). Noncommunicable diseases (NCDs) account for 60% of all fatalities in India, according to the Ministry of Health and Family Welfare of the Government of India. Diabetes, cardiovascular disease, cancer, chronic respiratory illness, and other non-communicable diseases are all examples of non-communicable diseases. The National Programme for the Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) involves medical education, school health awareness, and diabetic urban design to prevent and control major NCDs. Diabetes is a data management disease that exemplifies how collecting real-world health and treatment data enables integrated and personalized chronic illness management. When making collaborative treatment decisions, both patients and diabetic care professionals use continually gathered metabolic, pharmaceutical, and lifestyle data.
Diabetes self-management is aided by digital health technologies, such as digital health applications. Diabetes apps make it easier to undertake lifestyle changes for diabetes prevention and treatment and check the quality of blood glucose control and insulin dose. Other developments include the integration of Blood Glucose Monitoring with insulin calculators, automated insulin titration software, and remote coaching, which give patients with poorly controlled diabetes the extra support they need to improve critical outcomes, thereby improving market prospects in the coming years.
India Insulin Infusion Pump Industry Overview
Due to the existence of only a few big businesses operating internationally and locally, the insulin infusion pump industry is concentrated. The competitive landscape includes an examination of a few well-known worldwide and local organizations, such as Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care.
India Insulin Infusion Pump Market Leaders
-
Medtronic
-
Ascensia Diabetes Care
-
Insulet Corporation
-
Tandem Diabetes Care
-
Ypsomed
*Disclaimer: Major Players sorted in no particular order
India Insulin Infusion Pump Market News
- March 2022: Medtronic India launched MiniMed 780G, a next-generation closed-loop insulin pump system.
- February 2022: Hyderabad-based BlueSemi startup designed Eyva, a completely non-invasive glucose monitor, has been designed and made in India.
Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.3 Market Restraints
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Insulin Infusion Pump
5.1.1 Insulin Pump Device
5.1.2 Infusion Set
5.1.3 Reservoir
6. MARKET INDICATORS
6.1 Type-1 Diabetic Population
6.2 Type-2 Diabetic Population
7. COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Novo Nordisk
7.1.2 Sanofi
7.1.3 Eli Lilly
7.1.4 Medtronic
7.1.5 Insulet corporation
7.1.6 Ypsomed
7.1.7 Becton Dickinson and Company
- *List Not Exhaustive
7.2 COMPANY SHARE ANALYSIS
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
India Insulin Infusion Pump Industry Segmentation
An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump is composed of a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes. India's insulin infusion pumps market is segmented by component (pump device, infusion set, and reservoir). The report offers the value (in USD million) and Volume (in units Million) for the above segments.
| Insulin Infusion Pump | |
| Insulin Pump Device | |
| Infusion Set | |
| Reservoir |
Frequently Asked Questions
What is the current India Insulin Infusion Pump Market size?
The India Insulin Infusion Pump Market is projected to register a CAGR of greater than 3% during the forecast period (2024-2029)
Who are the key players in India Insulin Infusion Pump Market?
Medtronic, Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care and Ypsomed are the major companies operating in the India Insulin Infusion Pump Market.
What years does this India Insulin Infusion Pump Market cover?
The report covers the India Insulin Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the India Insulin Infusion Pump Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
India Insulin Infusion Pump Industry Report
Statistics for the 2024 India Insulin Infusion Pump market share, size and revenue growth rate, created by 糖心vlog传媒鈩� Industry Reports. India Insulin Infusion Pump analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
